Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
Oral Oncology , 07/14/09
Locati LD et al. - In RMSGCs further evaluations of EGFR targeting agents are advisable and should take place by appropriate tumor biological selection, differentiating ACC from non-ACC.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Saline Nasal Irrigation for Upper Respiratory Conditions
American Family Physician, 11/12/09
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/12/09
Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis
Journal of Asthma, 11/11/09
Today in Salivary Glands...keeping you current
Receive free subspecialty "5-minute updates" via email
A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer
Cancer, 11/25/09
Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
Cochrane Reviews, 10/09/09
Clinicopathologic similarities between Mikulicz disease and Kuttner tumor
American Journal of Otolaryngology, 11/04/09
Article Search
Sponsor


See Latest Articles


